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The immune response of A/J  mice to  the p-azophenylarsonate  (Ar) 1 hapten  has 
become one  of the  most  extensively characterized  idiotypic  systems.  As  originally 
defined by Nisonoff et al.  (I-3), the system takes advantage of the fact that 20-70% 
of  the  serum  anti-Ar  antibodies  bear  a  cross-reactive  idiotype  (CRI)  when  an 
appropriately absorbed rabbit antiserum is used. This finding has prompted a number 
of  studies  on  the  induction,  regulation,  and  structure  of  such  antibodies  (4-9). 
Recently, our attention has been directed  toward a  serologic and chemical study of 
the products of somatic cell fusion (10-12). Through a thorough understanding of the 
relationship  of these monoclonal  B  cell  products  to each other and  to the  induced 
serum antibody, we hope to approach, in molecular terms, an understanding of the 
precise chemical nature of the Ar idiotype, 
Several laboratories have recently studied the role of T  cells and their products in 
the arsonate system. Suppressor T  cells have been shown to bear idiotypic determi- 
nants similar to those found on B cells and/or their antibody products. Furthermore, 
arsonate-specific suppressor  factors have been characterized  as proteins  of between 
33,000 and 68,000 mol wt, bearing determinants encoded within the major histocom- 
patibility complex (13-16). However, a serious limitation of these studies has been the 
lack of single clonal products--especially ones that could be propagated indefinitely. 
The production of T  cell hybrids has led several investigators to use this technique 
to study T  cell  functions, T  cell surface markers, and T  cell products  (17-21).  The 
present  study  was  undertaken  with  the  aim  of identifying  such  antigenic-specific 
nonimmunoglobulin T  cell products in the A/J arsonate system. Our longwange goal 
is  to understand  the molecular relationships  between such  T  cell products  and  the 
products of B cell hybridomas with similar idiotypic characteristics.  Such studies are 
* Supported by grant PCM 79-23480 from the National Science Foundation and grant AI 12127 from 
the National Institutes of Health. 
i Abbreviations used in this paper: ABA and Ar, used interchangeably for p-azophenylarsonate; BSA, bovine 
serum albumin; CRI, cross-reactive idiotype; DMEM, Dulbecco's modified Eagle's minimal essential 
medium; DTH, delayed type hypersensitivity; HAT, hypoxanthine aminopterin thymidine; HGG,  human 
gamma globulin; HPLC, high-pressure liquid chromatography; MHC, major histocompatibility  complex; 
PBS, phosphate buffered saline; PEG, polyethylene glycol; SDS, sodium dodecyl sulphate;  PAGE, 
polyacrylamide  gel electrophoresis. 
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fundamental  to a  complete dissection of the interrelationships of T-B interactions in 
this genetically and chemically characterized idiotypic system. 
Materials  and  Methods 
Mice.  A/J mice (H-2  a) were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
All animals were 8-10 wk old at the time of initial immunizations. 
Preparation of Antigen and Antigen-coupled Cells.  The diazonium salt of Ar (Eastman Kodak 
Co.,  Rochester,  N.  Y.)  was  prepared  as  described by  Bach  et  al.  (13).  Activated Ar was 
conjugated to single cell suspensions of erythrocyte-free A/J splenocytes. Briefly, a  40-mM 
solution  of Ar  diazonium  salt  was  prepared  from  Ar.  A/J  spleen  cells were  washed  and 
resuspended  in  Dulbecco's modified  Eagle's minimal  essential  medium  (DMEM)  and  the 
erythrocytes lysed with  ammonium  chloride. Cells were  then  suspended  in  borate-buffered 
saline, pH 8.4, at a concentration of 1 X  107/ml and mixed with the solution of Ar diazonium 
salt. The final concentration of Ar was  10 mM. The reaction was stopped by the addition of 
cold phosphate-buffered saline, and the cells were washed and counted before use. The same 
preparation of Ar-coupled cells was used to prime for suppression, or alternatively to induce 
delayed type hypersensitivity (DTH) as described by Bach et al. (13). 
Immunization and  Challenge.  A  group  of mice was  primed for suppression by intravenous 
7  injection of 5 ×  10  Ar-coupled syngeneic cells (13). 5 d later, the mice were challenged with 25 
#1 of 10 mM Ar diazonium salt in one footpad, and with 25 #1 of saline in the other footpad. A 
second group of mice were primed for DTH by subcutaneous injection of 3 X  107 Ar-coupled 
cells and similarly challenged 5 d later. Footpad thickness was measured 24 h after challenge. 
The first group of mice showed minimal swelling, whereas the control group displayed a normal 
DTH. Spleens were removed from the suppressed mice for hybridization. 
Antisera.  Rabbit  anti-mouse immunoglobulin, rabbit  anti-CRI, and  goat  anti-rabbit Fc 
were prepared as previously described (2, 8-12). Monoclonal antibody (HP93G7) anti-Ar was 
previously produced in our laboratory and kindly supplied by Pila Estess. A.TH anti-A.TL was 
provided by three separate laboratories (Dr. E. S. Vitetta, Southwestern Medical School, Dallas, 
Tex., J.  A. Frelinger, University of Southern California, Los Angeles, Calif., and  Dr.  H. O. 
McDevitt, Stanford University School of Medicine, Stanford, Calif.), as well as the Research 
Resources Branch of the National Institutes of Health, Bethesda, Md. A.TL anti-A.TH was 
provided by Dr. D. C. Shreffler, Washington Univ. School of Medicine, St. Louis, Mo. Anti- 
Thy  1.1  and  1.2  antisera were  kindly provided by Dr.  D.  H.  Sachs,  National  Institutes of 
Health, and Dr. J. Forman, Southwestern Medical School, Dallas, Tex., B I0.BR anti-Bl0.D2 
was provided by Dr. Richard Cook, Southwestern Medical School, and was further absorbed 
with the parent BW cell line before use. 
Immunoadsorbents.  Ar was coupled to human gamma globulin (HGG) and it, as well as HGG, 
were coupled to activated Sepharose 4B  according to the method described by Cuatrecasas 
(22). 
Cell Fusion.  Spleen cells from  suppressed mice were  fused with  the azaguanine-resistant 
thymoma  line of AKR  origin,  BW  5147  (phenotype:  H-2  k,  Thy  1.1 +,  Ig-,  Ly  1-,  Ly  2-) 
(obtained  from  the  Salk Institute,  San  Diego, Calif.)  by a  modification of the  method  of 
Pontecorvo  (23).  Briefly, lymphoeytes and  BW  5147  cells were  mixed  at  a  ratio  of  10:1, 
centrifuged, and resuspended in 2 ml of a 40% solution of polyethylene glycol 1,000 in DMEM 
(Gibco  Laboratories,  Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.).  After  a  2-min 
incubation at 37°C, the suspension was slowly diluted by adding 6 ml of DMEM.  The cells 
were again pelleted, resuspended in hypoxanthine aminopterin thymidine (HAT) medium, and 
distributed into 96-well tissue culture plates (Costar, Data Packaging, Cambridge, Mass.) at a 
concentration of 3 X  l0  s cells/well. HAT medium was changed every fourth day. Microscopic 
cell growth was apparent  within  3 wk.  All the hybrids were assayed for binding to bovine 
serum albumin (BSA)-Ar (see below), and positive wells were cloned by growth at limiting- 
dilutions. 
Radioimmunoassays.  Culture supernates were tested for nonimmunoglobulin anti-Ar activity 
on BSA-Ar-coated polyvinyl microtiter plates by a modification of the method of Klinman et 
al.  (24).  An  anti-Ar titration  curve  was  constructed  of affinity-purified anti-Ar antibody 
(HP93G7)  and radiolabeled rabbit anti-mouse Ig as a detecting reagent (Fig. 1). On the basis A.  PACIFICO AND J.  D.  CAPRA  1291 
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FIG.  i.  Binding of HP93G7 anti-Ar antibodies to BSA-Ar (open symbols)  or BSA (closed symbols) 
to coated polyvinyl microtiter plates. Dilutions of specifically purified 93G7 hybridoma product 
with anti-arsonate activity were added to each well. The ordinate indicates the number of counts 
per  minute of tsSI-labeled rabbit  anti-mouse immunoglobulin bound to each well. From this 
experiment, 40 ng of HP93G7 was chosen for the inhibition assay. 
of this curve, a fixed point of 40 ng of HP93G7 was chosen, and culture supernates were tested 
for their ability to inhibit the binding of this murine anti-Ar to the test plate. 50 FI of culture 
supernate plus 50/~1 of the anti-Ar monoclonal antibody were added to each well and incubated 
3 h at room temperature. After further washing, 100 #1 of t25I-rabbit anti-mouse Ig was added. 
The plates were left overnight at 4°2, then washed extensively, and each well counted in a 
gamma counter. In the assays used in this report, the 100% figure (no inhibition) varies from 
10,000 to 20,000 cpm because of variation in specific activity of the 125I-rabbit anti-mouse Ig 
reagent. 
Btosynthetic Labeling.  2ells were centrifuged, washed twice with spinner salt solution, and 
then resuspended at a concentration of 3 ×  106/ml in labeling medium (25) supplemented with 
a  mixture of 3H-  (0.1 mCi/ml) or 14(3- (0.025  mCi/ml) labeled amino acids (New England 
Nuclear, Boston, Mass.).  For most  experiments, this mixture included arginine, lysine, and 
leucine. After 14-16 h incubation at 37°2, the supernates were harvested by centrifugation and 
stored at -70°12 until used. 
Gel Electrophoresis.  Samples were subjected to electrophoresis on 10% acrylamide slab gels, 
as  described by Laemmli (26).  The following molecular weight  standards were  used:  BSA 
(68,000), immunoglobulin  heavy and light chain (56,000 and 25,000), ovalbumin (44,000), and 
carbonic anhydrase  (30,000).  The  sodium dodecyl  sulfate  (SDS)-polyacrylamide gels  were 
fluorographed as described by Bonner and Laskey (27). 
lmmunoprecipitation.  Appropriately titered antisera were  used to immunoprecipitate either 
biosynthetically radiolabeled Ar eluates or whole supernates. Second-step precipitations were 
accomplished with goat anti-mouse Ig, goat anti-rabbit Ig, or rabbit anti-mouse Ig as indicted 
in  the  individual experiments.  All  precipitates  were  washed  by  procedures  described  by 
Shackelford and Strominger (28). 
High-Pressure Liquid Chromatography (HPLC).  The 3H- and 14C-labeled T cell products eluted 
from a HGG-Ar column were mixed with a 3H:142 cpm ratio of 3:l or 4:1 with  1.0 mg HGG 
as carrier and 0.6 ml of 0.1 M ammonium bicarbonate, pH 8.5. The samples were digested at 
37°C  for  either  4  or  24  h  with  Tos-Phe-SHsCl-trypsin (Worthington Biochemical 2orp., 
Freehold, N. J.)  at a  ratio of 1:10 the amount of HGG and lyophilized. Peptides were then 
dissolved in 2% acetic acid and resolved on a high-pressure liquid chromatograph equipped 
with either a  micro-bondapak 218 column (Waters Associates,  Inc., Milford, Mass.;  column 
dimensions 0.4 X 30.0  cm) or a  radial compression module system (Waters Associates,  Inc.) 
using a reverse-phase cartridge. Three different HPLC systems were used for these analyses: a 
standard C18 column in which the aqueous phase was  2% acetic acid and the organic phase 
acetonitrile, and a second standard (218 column system where the aqueous phase was ammonium 
bicarbonate and the organic phase acetonitrile. Finally, the acetic acid-acetonitrile system was 1292  T  CELL  HYBRIDS WITH  ARSONATE  SPECIFICITY 
used  with the radial compression  module. In each system,  over a period of 45 min, a linear 
gradient  of 0-25%  acetonitrile  was  generated  using  a  curve  6  of the  model  660  solvent 
programmer (Waters Associates, Inc.). Isocratic elution at 25% acetonitrile was continued after 
completion of the gradient for a period of 15 min. The flow rate varied between 0.5 and 1 ml/ 
rain, depending upon the particular experiment. Fractions were collected into scintillation vials 
at 0.5-rain  intervals.  Water (0.5 ml) and scintillation  fluid were added to the vials and samples 
were counted under double label (3H-14C) conditions  (29). 
Results 
Construction of T  Cell Hybrids.  Initially, mice were immunized intravenously with 
Ar-coupled spleen cells and tested by footpad swelling induced by Ar-coupled spleen 
cells. Those mice that clearly demonstrated absence of the DTH reaction were killed 
by cervical dislocation,  and  their spleens  were  removed for hybridization  with  the 
AKR thymoma, BW5147. 
Three separate fusions were performed and cell growth was observed in 324 of 1,080 
wells, and the hybrids in the 324 positive-growth wells were transferred to larger wells. 
A radioinhibition  assay (Materials and Methods)  was performed on the 238 hybrids 
that survived passage. A sample of the initial screening of 48 of these 238 wells tested 
for inhibition of the binding of the hybridoma product to BSA-Ar-coated polyvinyl 
plates  is  shown  in  Fig.  2.  Wells  5,  36,  and  41  showed  considerable  inhibition  of 
binding,  and  the  cells in  these  wells  were selected  for further study.  Several other 
hybrids inhibited  in intermediate range (for example, those in wells  1, 4,  16,  18,  38, 
39, 42, and 47). These latter clones were frozen in liquid nitrogen for future analysis. 
The hybrids in wells 3, 5, and 41  were cloned by limiting-dilution;  for this study, 
the hybrid clone originally derived from well 5 is referred to as T34G6, and the clone 
derived  from well  36,  T33D5.  This latter  clone was subsequently  subcloned.  After 
subcloning,  the  T33D5  hybrid  continued  to produce  nonimmunoglobulin  antigen- 
binding  material.  As  shown  in  Fig.  3,  this  product  could  be  detected  in  culture 
supernates even at dilutions of 1:16. 
Characterization of the Tcell Hybrids.  The hybrid nature of each clone was confirmed 
by growth in HAT medium. A subclone of T33D5 was tested for Thy-1 antigens and 
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FIG.  2.  An example of the screening assay for nonimmunoglobulin Ar-specific T  cell  products. 
This illustrates tests on 48 of the 238 growth positive wells. No inhibition was observed in over two- 
thirds of the wells. Of the approximately one-third that did inhibit the reaction, some (for example, 
wells 5, 36, and 41) inhibited markedly and were chosen for further study. A.  PACIFICO AND J. D. CAPRA  1293 
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FIG.  3.  Titration  of the culture Ar eluate of a  subclone  at  T33D5  in  the  radioinhibition  assay. 
Activity could be detected at a  1:8 to  1:16 dilution. The Ar eluate was derived from 2  X  10  7 cells. 
>95%  of the cells contained  both Thy-l.1  and Thy-l.2 on their surface by indirect 
immunofluorescence. To test for the presence of the H-2 complex of the A/J parent 
in the hybrids, the T33D5 subclone was tested by indirect immunofluorescence with 
B10.BR anti-B10.D2  previously absorbed with the BW  (AKR)  parent line.  A  weak 
but clearly positive reaction was evident. Controls done during this set of experiments 
indicated  that the T33D5 clone did not express immunoglobulin or Fc receptors on 
its surface. 
Sixteen clones, nine of which  secreted the Ar specific-product and seven that did 
not,  were  tested  for direct  cytotoxic effector cell  activity  following the  method  of 
Forman and Mrller (30)  in which individual clones are mixed with P815 target cells 
in the presence of phytohemagglutinin.  This procedure detects cytotoxic activity of 
any specificity. Because none of the clones tested caused lysis of the P815 target cells, 
it  is  unlikely  that  any express cytotoxic T  cell activity.  (These studies  were kindly 
done by Dr. James Forman.) 
On  the  basis  of biosynthetically  incorporated  leucine,  arginine,  and  lysine,  we 
estimate that from 0.1  to 0.2% of the material in culture supernates is the arsonate- 
specific product. Whether this is actively secreted, shed from living cells, or released 
after cell  death  and  lysis  has  not  been  investigated.  The  amount  was  reasonably 
constant  over the 4  mo these clones have been extensively studied  and, in addition, 
the Ar-specific product appears stable as no proteolytic breakdown has been observed 
in stored culture fluids. 
Isolation of At-specific T Cell Hybrid Products.  Antigen-specific T  cell products were 
isolated from three of the cloned T  cell hybrids by biosynthetic labeling with either 
[3H]leucine or a  mixture of [3H]leucine,  [3H]arginine, and  [3H]lysine. Other biosyn- 
thetic studies involved [14C]amino acids as outlined below. In addition, unlabeled T 
cell hybrid products were isolated from one clone (T33D5). 
Table I  illustrates one experiment with the T33D5 clone biosynthetically labeled 
with [aH]leucine.  1 ml of culture supernate was collected and a  portion tested in the 
radioimmunoinhibition  assay;  in  this  particular  experiment  ~3.1%  inhibition  was 
found.  After dialysis,  1 ml of this radioactive supernate was placed on an HGG-Ar 
column that was then exhaustively washed with phosphate-buffered saline (PBS). The 1294  T  CELL HYBRIDS WITH ARSONATE SPECIFICITY 
TABLE  I 
Inhibition of Binding by T Cell Hybridoma Products 
Inhibitor  Inhibition 
cpm  % 
PBS  15,000  0 
T33D5 supernate  10,300  31.4 
T33D5 Ar Eluate  1,400  90.7 
T33D5 effluent  12,600  16.0 
BW51 supernate  14,600  2.7 
T33B3 supernate  14,600  2.7 
Ar-BSA-coated plates plus HP93G7 anti-Ar + 125I-rabbit anti-mouse Ig. 
T  cell product was then isolated by hapten elution with 0.1  MAr.  Both the effluent 
and  the  eluate  were collected,  dialyzed,  lyophilized,  and  resuspended  in  250  /~1  of 
PBS. As shown in Table I, the T35D5 arsonate eluate inhibited  the reaction >90%, 
whereas the column effluent was inhibitory at the level of only 16%. Both the BW5147 
supernate  and  T33B3,  a  T  cell  hybrid  that  formerly had  been  producing  the  Ar- 
specific product but that had ceased to produce the specific product, gave background 
inhibition levels. 
When  the  Ar-specific  eluate  was  applied  to  an  HGG  column  with  no  hapten 
coupled,  all radioactivity appeared  in  the effluent.  In addition,  after elution  of an 
active T  cell supernate with the Ar hapten, further stripping of the column with 5 M 
guanidine resulted in the recovery of relatively few counts. 
Serologic Characterization Arsonate-specific T  Cell Hybrid Products.  Because one is able 
to  isolate  relatively  large  amounts  of  biosynthetically  labeled  T  cell  hybridoma 
products with antigen specificity with the techniques employed, experiments could be 
done on  the  purified  material  rather  than  on  whole culture  supernates.  In  typical 
experiments,  3,000  cpm  of leucine-,  arginine-,  and  lysine-labeled  Ar  eluates  were 
placed  in  serial  tubes  and  antisera  added.  Controls  always  included  the  use  of 
hyperimmunized mouse or rabbit antisera. After overnight incubation (Materials and 
Methods), the pellets were counted and invariably all (3,000 +__ 200 cpm) the counts 
were in the pellet or none (400 +  50 cpm) of the counts were in the pellet. This is a 
substantially different  system than employed by other investigators studying T  cell 
products and is one of the significant advantages of isolating hapten-specific material. 
As can  be seen,  of all  the  antisera  tested,  only rabbit  anti-CRI and A.TH  anti- 
A.TL  resulted  in  specific  precipitation  of the  T33D5  T  cell  hybridoma  product. 
Similar studies have been done on the products of three clones. Similar experiments 
were  also  performed  on  unfractionated  biosynthetically  labeled  supernates.  These 
studies demonstrate that all three T  cell hybrids produce a  product  that has deter- 
minants that  are recognized by a  rabbit  anti-CRI, as well as contain  determinants 
that  are  recognized  by antisera  directed  against  the  whole  I  region  of the  murine 
major histocompatibility complex. 
Chemical Characterization of At-specific  T Cell Hybrid Products.  The Ar eluates from all 
three  products  were  run  both  on  polyacrylamide  slab  as  well  as  tube  gels  with 
appropriate molecular weight markers, and the apparent molecular weight of each is 
62,000.  Fig.  4  illustrates  an  SDS  slab  gel  of whole  biosynthetically  labeled  T  cell 
supernate (lane  1) as well as the Ar eluate from an HGG-Ar column (lane 2).  As can A.  PACIFICO AND J.  D. CAPRA  1295 
FiG. 4.  Ftuorographic  analysis of biosynthetically labeled T35D5 supernate (lane 1) and the Ar 
eluate (lane 2). Molecular weight markers are indicated on the right. 
be seen, the Ar eluate is a single band of 62,000 daltons. This band is clearly evident 
in the whole cell supernate. 
In some experiments  with  biosynthetically labeled  material,  a  stained  band  ap- 
peared to coincide with the radiolabeled band. In addition, when cold Ar eluate was 
run on SDS-polyacrylamide gel electrophoresis (PAGE), a single band was evident in 
the 62,000 dalton range. When the BW line was biosynthetically labeled, its culture 
supernate never showed a band at 62,000 daltons, and when its culture supernate was 
passed over an  HGG-Ar column and eluted  with  Ar hapten,  no such material  was 
noted. 
Complete reduction and alkylation of the Ar eluate did not appreciably change its 
apparent  molecular weight.  Thus,  the T  cell  product appears  to be either  a  single 
62,000-dalton molecule, or multiple 62,000-dalton subunits noncovalently associated. 
Tryptic Peptide Analysis of Two Ar-specific T  Cell Hybrid Products.  Fig.  5  shows the 
results of an HPLC analysis of the tryptic peptides of two of the T cell products. Each 
of these clones had  been  run several  times  under single  label  conditions, and  four 
separate analyses were performed with double labels. In each instance, 14-20 peptides 
were clearly resolved  by HPLC and,  in  all  cases,  the  vast  majority of the peptides 
were shared  by both T  cell  products.  In each  instance,  however, from two to  four 
peptides were clearly distinct. HPLC resolves peptides primarily on the basis of their 1296  T  CELL  HYBRIDS  WITH  ARSONATE  SPECIFICITY 
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FxG.  5.  HPLC  analysis of tryptic digests of the T35D5  and T34G6  specifically purified T  cell 
products. 3H-labeled (--) T33D5 is compared with 14C-labeled  (---) T34G6. The four peptides that 
are clearly distinct between the two T  cell products are indicated by arrows. All other peptides 
appear identical by this analysis. This particular analysis was performed on a  radial compression 
module with an acetic acid-acetonitrile gradient (Materials and Methods). 
hydrophobicity, and has proven in our hands  to be a  rapid  and simple method of 
separating tryptic peptides. Its resolution capacity is equal to or exceeds that of ion 
exchange  chromatography.  These  results  indicate  that,  whereas  these  two  T  cell 
products are remarkably similar, they have unique features as well. 
Discussion 
This  report  concerns  the  initial  characterization  of the  products  of three  T  cell 
hybrids. Each T  cell product is Ar-specific and bears determinants related to both the 
Ar CRI and determinants encoded by the murine major histocompatibility complex. 
The ease of production of these hybrids, their clonal nature, the substantial amounts 
of product  produced,  and  the stability of the cell  lines  provide an opportunity  for 
extensive chemical  and  serologic  investigation  of what  are  likely to  be  important 
immunoregulatory molecules in the arsonate idiotypic system. 
Evidence that  These Cell Lines are T-T Hybrids.  Growth in HAT media supports the 
view that these cell lines are somatic cell hybrids. Additional characterization of one 
T  cell hybrid (T33D5)  indicated the presence of at least a portion of chromosome 17 
of the A/J parent by the presence of cell surface antigens that reacted with antisera 
to H-2D  d glycoproteins. The evidence that these are T  cell hybrids is as follows:  (a) 
Immunochemical characterization of the product indicates the presence of no known 
immunoglobulin constant region markers; (b) Neither immunoglobulin nor Fc recep- 
tors could be demonstrated on the cell surface on any of the hybrid lines; (c) all hybrid 
lines tested expressed both the Thy-1.1  and Thy-1.2 cell surface markers, indicating 
that, unless the A/J T  cell genes in a B cell have been derepressed, the fusion partner 
for the AKR thymoma line was an A/J T  cell. This possibility must be considered in 
view of the recent report by Taussig et al. (31) who demonstrated that this same AKR 
thymoma could be successfully hybridized to the IgM-bearing (BALB/c ×  NZB) F1 
B cell lymphoma WH 1231.  Surprisingly, they were able to demonstrate the presence 
of both the Thy-1.1 and Thy-1.2 allelic products in at least some of their hybrid lines. A.  PACIFICO  AND j.  D.  CAPRA  1297 
Thus, the evidence is conclusive that these are, indeed, somatic cell hybrids and, very 
likely, that they are T-T hybrids. 
A  Single Chain Bears Both the Serologic Characteristics of lmmunoglobulin-Variable-Region 
and MHC Determinants.  A significant advantage of the system employed in this study 
is that a highly purified biosynthetically labeled T cell product isolated by its antigen- 
binding characteristics can be tested essentially in an all or none fashion in a serologic 
assay. As shown in Table II, the only two antisera that immunoprecipitated the Ar 
eluate  were directed against  the  A/J  Ar  CRI  or  the  entire I  region  of the  major 
histocompatibility complex (MHC). The immunoprecipitates in both instances were 
run on SDS polyacrylamide gels  and demonstrated a  single band of 62,000 dalton, 
whereas  the  supernates,  in  both  instances,  revealed  no  bands  whatsoever.  In  all 
instances, where no counts were recovered in the immunoprecipitates, SDS slab gel 
analysis revealed no bands. These and other data unequivocally document that  the 
same  molecules that  bear the CRI  bear determinants  encoded by the 1 region  of 
murine MHC. 
Several different A.TH anti-A.TL antisera were used in these studies with identical 
results. Although there is a  remote possibility that the specificity we are detecting is 
at the Qa-1 locus, the strain combinations used argues that the more likely specificities 
are directed against  the I  region. Further evidence for the specificity of the I  region 
determinants being of A/J origin comes from the demonstration that the D region of 
the A/J  strain  is expressed on the cell surface of at  least one of the hybrid clones, 
T33D5. This indicates that at least a portion of the A/J  17th chromosome is present 
in one of the T  cell hybrids. 
The binding of the Ar-specific T  cell product to rabbit anti-CRI does not indicate 
idiotypic identity between the T  cell and B cell product to which the anti-CRI was 
raised. This is an important issue and one generally confused in idiotypic studies in 
general,  and  in  idiotypic analyses of T  cells and  their products  in  particular.  For 
example, in standard inhibition assays employed in our laboratory for both the serum 
Ar antibodies as well as anti-Ar hybridoma products, the T  cell products generated in 
these experiments gave little,  if any, inhibition.  Thus, although  in  a  binding assay 
TABL~  II 
Serological Characterization of T33D5 Arsonate-specific T Cell Product 
Antiserum  Precipitate 
gprn 
Rabbit anti-CRI  2,857 ±  275 
A.TH anti-A.TL  1,981  ±  127 
A.TL anti-A.TH  405 ±  37 
Anti-H-2K  k  330 ±  44 
Anti-H-2D  d  487 ±  56 
Anti-Slp  550 ±  65 
Rabbit anti-human (34  604:1:93 
Rabbit anti-mouse Ig  783 :tz 83 
Mouse anti-human IgGK  468 ±  50 
Goat anti-mouse Ig  403 +  47 
Goat anti-rabbit Ig  409 +  56 
Each reaction system included 3,000 cpm of ~H leucine, arginine, and lysine 
biosynthetically labeled Ar eluate and 50 #1 of appropriate antisera. 1298  T  CELL HYBRIDS WITH ARSONATE SPECIFICITY 
rabbit anti-CRI can recognize these T  cell products, they are not identical to the B 
cell idiotype. It should be emphasized that  in the well-defined Ar idiotypic system, 
isolated heavy chains are not completely inhibitory and rarely even inhibit to 50%. In 
addition, certain hybridomas are known to bind to the rabbit anti-CRI reagent, but 
not  inhibit the standard  assay  (32).  Thus,  it is not  at  all surprising that  the single 
chain T  cell product does not bear all of the determinants that comprise the CRI. 
Nonetheless, it is likely that simple binding would be sufficient either to stimulate, to 
suppress, or to kill (with complement or with an auxiliary cell) cells and, thus, could 
explain the effect of anti-B cell idiotypic antisera on T  cell function. 
Preliminary experiments designed to narrow the specificity within the I region have 
been limited primarily by the nature of the antisera available. 3R anti-5R as well as 
antisera directed against  the E/C subregion  (anti-Ia.7)  provided by several investi- 
gators as well as the Division of Research Resources, National Institutes of Health, 
specifically immunoprecipitated these T  cell products.  However, most  Ia.7 antisera 
potentially  contain  I-J  reactivity,  and  the  anti-I-J  sera  employed  contain  other 
specificities, particularly to viral proteins. Experiments are in progess with recently 
available hybridoma antibodies to the murine I-A  and and I-E/C subregion. Thus, 
the precise I  region determinants located on these T  cell products are unclear at the 
present time. 
Chemical Characterization of the T Cell Products.  By SDS-PAGE, the molecular weight 
of the Ar-specific material derived from the three T cell lines appeared identical. They 
reacted similarly in serological analyses as well. Preliminary analysis of one of the T 
cell supernates by molecular exclusion chromatography in neutral buffers indicates 
that the bulk of the arsonate-specific product elutes in the molecular weight range of 
50-70,000. Some activity was detected in the  120-150,000 range as well (A. Pacifico 
and J.  D. Capra. Unpublished observations). Thus, by both SDS-PAGE analysis as 
well  as by column chromatography, the active material  appears  to be primarily a 
single  chain,  and  probably does  not  exist,  at  least  in  appreciable  amounts  in  the 
culture supernates, as a two-chained dimer. It may, however, exist in that form on the 
cell surface. 
Although  these  products  could  not  be  distinguished  either  serologically  or  by 
molecular  weight  analysis,  peptide  map  comparisons  clearly  demonstrated  that, 
whereas the vast majority of the tryptic peptides were common to the products of all 
three of the T cell lines, each contained unique peptides. Thus, for example, as shown 
in  Fig.  5,  an  HPLC  comparison  of T33D5  and  T33G6  indicates  that  15  tryptic 
peptides are common to the two molecules, whereas each molecule has two peptides 
not found in the other molecule. These results could be explained by a difference of 
as few as two amino acids between the two hybridoma products. Analysis of a third 
clone indicated  further differences. These experiments suggest  that,  whereas  these 
separately derived Ar-specific T cell products are remarkably similar both serologically 
and chemically, there are individual differences in their primary structures, just  as 
there are in the idiotype positive B cell hybridoma products in the Ar system (10-12). 
Barring unexpected serologic cross-reactivity, the data presented strongly suggest 
that a single polypeptide chain bears antigenic determinants thought to be encoded 
on  different  chromosomes.  Thus,  the  antigen-binding  function  and  the  CRI  are 
encoded on  chromosome 6  and  12  (light  and  heavy chain  loci),  whereas  I  region 
structures are encoded on chromosome 17. Four possibilities should be considered for A.  PACIFICO AND J.  D. CAPRA  1299 
this  unprecedented  finding:  (a)  the  variable region  loci  have been  duplicated  and 
they, or structures related to them, are encoded on chromosome 17;  (b)  the I  region 
loci have been duplicated and exist on chromosomes 6 and/or  12 as well as chromo- 
some  17;  (c) protein or RNA ligases exist that splice either nucleic acids or proteins 
from different chromosomes or (d) the loci (possibly I-J because previous results seem 
to rule out I-A or I-E/C [33])  do not encode the structural  genes for the polypeptide 
chains  in  question,  but  rather encode modifying enzymes that  actually dictate  the 
serologic specificities. This latter possibility has been suggested previously by Parish 
et al. (34)  and may be the most conservative explanation of our data. 
The relationship of these T  cell products to molecules described by other investi- 
gators  is  speculative  at  present  because  we  have  not  determined  any  functional 
activity for these Ar-specific products. Our approach has been to search for a specific 
molecule and now, with this homogeneous product available, design experiments to 
test potential function. Others have searched for a  function, and then attempted to 
characterize  the  molecules.  Nonetheless,  the  relationships  of these  antigen-specific 
idiotype-positive I  region-containing  structures  to  suppressor,  helper,  or  allogeneic 
effector factors,  or to  the T  cell  receptor problem  itself,  is approachable now  that 
cloned  cell  lines  are  available  that  secrete  significant  amounts  of  homogeneous 
molecules that appear to link two important loci of the immune system. 
Summary 
T  cell hybrids have been constructed between the BW5147 thymoma cell line and 
A/J splenocytes from mice suppressed with the p-azophenylarsonate hapten.  Three 
independently derived cloned lines have been characterized. Each secretes or sheds a 
62,000-dahon  antigen-specific product bound by rabbit antisera directed against the 
arsonate cross-reactive idiotype.  In addition,  each of the antigen-specific molecules 
contains determinants encoded within the I region of the murine major histocompat- 
ibility complex. Peptide mapping analysis indicates that, whereas these molecules are 
remarkably similar, each is individually distinct in primary structure. 
The availability of cloned T cell lines that produce antigen-specific idiotype-positive 
I  region-containing  products  should  facilitate  a  more  thorough  dissection  of the 
interrelationships of T-B interactions in the arsonate idiotypic system. 
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